von Moltke Lisa has filed 36 insider transactions across 3 companies since January 2023.
Most recent transaction: a grant/award of 400000 shares of Zenas BioPharma, Inc. ($ZBIO) on April 15, 2025.
Activity breakdown: 0 open-market purchases and 7 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 15, 2025 | Zenas BioPharma, Inc. | $ZBIO | von Moltke Lisa | See Remarks | A | Stock Option (Right to Buy) | 400000 | $0.00 | 400,000.0000 | 41,800,802 | 9999.99% | 0.96% |
| Feb. 15, 2025 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | M | Common Stock | 2969 | $0.00 | 35,384.0000 | 0 | 9.16% | 0.00% |
| Feb. 15, 2025 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | M | Common Stock | 8907 | $0.00 | 44,291.0000 | 0 | 25.17% | 0.00% |
| Feb. 15, 2025 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | M | Restricted Stock Units | 8907 | $0.00 | 26,718.0000 | 0 | 25.00% | 0.00% |
| Feb. 18, 2025 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | S | Common Stock | 4416 | $0.81 | 39,875.0000 | 0 | 9.97% | 0.00% |
| Feb. 15, 2025 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | M | Restricted Stock Units | 2969 | $0.00 | 23,750.0000 | 0 | 11.11% | 0.00% |
| Feb. 7, 2025 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | A | Stock Option (Right to Buy) | 650000 | $0.00 | 650,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 18, 2024 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | S | Common Stock | 977 | $0.54 | 32,415.0000 | 0 | 2.93% | 0.00% |
| Nov. 15, 2024 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | M | Common Stock | 2969 | $0.00 | 33,392.0000 | 0 | 9.76% | 0.00% |
| Nov. 15, 2024 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | M | Restricted Stock Units | 2969 | $0.00 | 26,719.0000 | 0 | 10.00% | 0.00% |
| Oct. 28, 2024 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | S | Common Stock | 4334 | $0.69 | 30,423.0000 | 0 | 12.47% | 0.00% |
| Oct. 27, 2024 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | M | Common Stock | 13744 | $0.00 | 34,757.0000 | 0 | 65.41% | 0.00% |
| Oct. 27, 2024 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | M | Restricted Stock Units | 13744 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 16, 2024 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | S | Common Stock | 973 | $0.84 | 21,013.0000 | 0 | 4.43% | 0.00% |
| Aug. 15, 2024 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | M | Common Stock | 2969 | $0.00 | 21,986.0000 | 0 | 15.61% | 0.00% |
| Aug. 15, 2024 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | M | Restricted Stock Units | 2969 | $0.00 | 29,688.0000 | 0 | 9.09% | 0.00% |
| June 4, 2024 | Tvardi Therapeutics, Inc. | $TVRD | von Moltke Lisa | Not found | A | Stock Option (Right to Buy) | 195000 | $0.00 | 195,000.0000 | 1,516,336 | 9999.99% | 12.86% |
| June 4, 2024 | Tvardi Therapeutics, Inc. | $TVRD | von Moltke Lisa | Not found | A | Common Stock | 150647 | $0.00 | 183,009.0000 | 1,516,336 | 465.51% | 9.93% |
| May 15, 2024 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | S | Common Stock | 939 | $0.94 | 19,017.0000 | 0 | 4.71% | 0.00% |
| May 15, 2024 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | M | Common Stock | 2968 | $0.00 | 19,956.0000 | 0 | 17.47% | 0.00% |
| May 15, 2024 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | M | Restricted Stock Units | 2968 | $0.00 | 32,657.0000 | 0 | 8.33% | 0.00% |
| Feb. 14, 2024 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | A | Stock Option (Right to Buy) | 213750 | $0.00 | 213,750.0000 | 0 | 9999.99% | 0.00% |
| Feb. 16, 2024 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | S | Common Stock | 4400 | $1.08 | 16,988.0000 | 0 | 20.57% | 0.00% |
| Feb. 14, 2024 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | A | Stock Option (Right to Buy) | 287905 | $0.00 | 287,905.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | A | Restricted Stock Units | 35625 | $0.00 | 35,625.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2024 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | M | Restricted Stock Units | 11875 | $0.00 | 35,625.0000 | 0 | 25.00% | 0.00% |
| Feb. 15, 2024 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | M | Common Stock | 11875 | $0.00 | 21,388.0000 | 0 | 124.83% | 0.00% |
| Oct. 30, 2023 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | S | Common Stock | 4232 | $1.35 | 9,513.0000 | 0 | 30.79% | 0.00% |
| Oct. 27, 2023 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | M | Common Stock | 13745 | $0.00 | 13,745.0000 | 0 | 9999.99% | 0.00% |
| April 27, 2023 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | A | Restricted Stock Units | 27489 | $0.00 | 27,489.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2023 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | M | Restricted Stock Units | 13745 | $0.00 | 13,744.0000 | 0 | 50.00% | 0.00% |
| June 1, 2023 | Tvardi Therapeutics, Inc. | $TVRD | von Moltke Lisa | Director | A | Common Stock | 32362 | $0.00 | 32,362.0000 | 53,872,038 | 9999.99% | 0.06% |
| June 1, 2023 | Tvardi Therapeutics, Inc. | $TVRD | von Moltke Lisa | Director | A | Stock Option (Right to Buy) | 44961 | $0.00 | 44,961.0000 | 53,872,038 | 9999.99% | 0.08% |
| Feb. 3, 2023 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | A | Restricted Stock Units | 47500 | $0.00 | 47,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 3, 2023 | Seres Therapeutics, Inc. | $MCRB | von Moltke Lisa | See Remarks | A | Stock Option (Right to Buy) | 95000 | $0.00 | 95,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2023 | Tvardi Therapeutics, Inc. | $TVRD | von Moltke Lisa | Director | A | Stock Option (Right to Buy) | 45841 | $0.00 | 45,841.0000 | 4,471,130 | 9999.99% | 1.03% |